| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/14/2009 | EP2012758A2 Inhibitors of the task-1 and task-3 ion channel |
| 01/14/2009 | EP1917242B1 Azabicyclo [3.1.0]hexylphenyl derivatives as modulators of dopamine d3 receptors |
| 01/14/2009 | EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 01/14/2009 | EP1686989B1 Use of 1,2-diaza-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/14/2009 | EP1684742B1 Use of 1-oxadibenzo [e,h] azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/14/2009 | EP1588707B1 Stable solid medicinal composition for oral administration of ramosetron |
| 01/14/2009 | EP1567164B1 Use of loxapine for the manufacture of a medicament for the treatment of pain |
| 01/14/2009 | EP1565173B1 Composition and its use for treating neuropathic sensory loss |
| 01/14/2009 | EP1515732B1 Cerebral protection with a gas comprising xenon |
| 01/14/2009 | EP1497309B1 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 01/14/2009 | EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1429769B1 New formulations and use thereof |
| 01/14/2009 | EP1395567B1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1323716B1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | EP1297142B1 Dual specificity antibodies and methods of making and using |
| 01/14/2009 | EP1283057B1 Cell proliferation inhibitors |
| 01/14/2009 | EP1278537B1 Compositions for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
| 01/14/2009 | EP1258484B1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 01/14/2009 | EP1183025B1 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites |
| 01/14/2009 | EP1087768B1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 01/14/2009 | EP0841937B2 Use of betaglycan to reduce scarring |
| 01/14/2009 | CN101346385A New compounds |
| 01/14/2009 | CN101346377A Aryl-isoxazol-4-yl-imidazoy1, 5-A pyridine derivatives |
| 01/14/2009 | CN101346372A Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 01/14/2009 | CN101346368A Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
| 01/14/2009 | CN101346366A Benzochromene derivatives |
| 01/14/2009 | CN101346356A Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 01/14/2009 | CN101346154A Water-soluble films comprising low-viscosity alginates |
| 01/14/2009 | CN101346144A Therapeutic uses of steroidal compounds |
| 01/14/2009 | CN101346138A Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343317A Brain peptide, preparation and uses thereof |
| 01/14/2009 | CN101343299A Lxeris sonchifolia(bunge)hance flavone extract, preparation method and application thereof |
| 01/14/2009 | CN101343253A 2-amido-4, 5-diaryl miazines compound, preparation and pharmaceutical use thereof |
| 01/14/2009 | CN101342363A Preparation of sedative and brain-invigorating oral liquid |
| 01/14/2009 | CN101342352A Drop pill for treating neurasthenia and preparation method thereof |
| 01/14/2009 | CN101342345A Chinese medicinal herb capsule for drug rehabilitation and preparation thereof |
| 01/14/2009 | CN101342320A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342311A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342310A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342309A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342308A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342307A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342305A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342304A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342259A Method for extracting alkaloid valid target from hooked uncaria leaf, with hook stem branch or full grass and uses thereof |
| 01/14/2009 | CN101342250A Bolus for clearing away heat of the upper part of the body |
| 01/14/2009 | CN101342248A Medicine for treating sciatica |
| 01/14/2009 | CN101342222A Medicament composition for preventing birth defection and improving memory |
| 01/14/2009 | CN101342221A Medicament composition for preventing birth defection and improving memory |
| 01/14/2009 | CN101342217A Quick-effective pain relieving traditional Chinese medicine liniment for treating advanced cancer and preparation method thereof |
| 01/14/2009 | CN101342213A Medicament composition for preventing birth defect and improving memory |
| 01/14/2009 | CN101342212A Medicament composition for preventing birth defection and improving memory |
| 01/14/2009 | CN101342211A Pharmaceutical composition for preventing birth defection and improving memory |
| 01/14/2009 | CN101342200A Patrinai villosa tablet and preparation method |
| 01/14/2009 | CN101342173A Application of lobeline in preparing medicament for treating apoptosis of the nerve cell |
| 01/14/2009 | CN101342153A Risperidone osmotic pump controlled release tablets and preparation method thereof |
| 01/14/2009 | CN101341982A Compound milk formulation for skull infantile metopism-premature metopism periodic time speed acceleration |
| 01/14/2009 | CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
| 01/14/2009 | CN100451004C Novel quinoline,Tetrahydroquinazoline,And pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/14/2009 | CN100450551C Recombinated adeno-associated virus genes vaccine for prevention and cure of Alzheimer disease and use thereof |
| 01/14/2009 | CN100450539C Use of medicinal composition containing pilose antler for treating chronic brain blood supply deficiency |
| 01/14/2009 | CN100450485C 5-HT 1a receptor subtype agonists |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/14/2009 | CN100450475C Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476740 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions |
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476689 Therapeutic compositions for intranasal administration which include KETOROLAC |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
| 01/13/2009 | US7476670 anticancer/antiproliferative activity; antifungal agents; protein kinases inhibitors in perticular Focal Adhesion Kinase inhibitors and fungal CIV1 protein kinase inhibitors; N-[6-(5,6-dichloro-2,3-dihydro-1H-indol-1-yl)-9H-purin-2-yl]-1,4-cyclohexanediamine dihydrochloride |
| 01/13/2009 | US7476668 Thiadiazine derivatives and use thereof as positive AMPA receptor modulators |
| 01/13/2009 | US7476665 Benzodiazepine CGRP receptor antagonists |
| 01/13/2009 | US7476664 Bis-2-difluoro-pyrrolo[2,1-C][1,4]benzodiazepine dimers |
| 01/13/2009 | US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 01/13/2009 | US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors |
| 01/13/2009 | CA2445132C Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2397785C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 01/13/2009 | CA2385402C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 01/13/2009 | CA2346506C Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 01/13/2009 | CA2301032C A method of preventing or treating estrogen-dependent diseases and disorders |
| 01/13/2009 | CA2189762C Use of no scavengers, inhibitors or antagonists in the treatment of migraine |
| 01/08/2009 | WO2009006548A2 Treatment for anxiety |
| 01/08/2009 | WO2009006185A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 01/08/2009 | WO2009006046A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | WO2009005729A1 Gamma secretase modulators |
| 01/08/2009 | WO2009005471A1 Aryl and heteroaryl substituted isoindole derivatives as bace inhibitors |
| 01/08/2009 | WO2009005470A1 Aryl and heteroaryl substituted isoindole derivatives as bace inhibitors |
| 01/08/2009 | WO2009005459A1 Phenyl-1,2, 3,4-tetrahydroisoquinolinone derivatives and their use in the treatment of a pain disorder |
| 01/08/2009 | WO2009005172A1 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | WO2009005033A1 Agent for improving dysfunction due to neuropathy and rho kinase activation inhibitor |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |